BNRE:NYE-Brookfield Reinsurance Ltd. (USD)

COMMON STOCK | Insurance - Reinsurance |

Last Closing

USD 49.29

Change

+0.48 (+0.98)%

Market Cap

N/A

Volume

4.82K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Insurance - Reinsurance

Symbol Name Price(Change) Market Cap
RNR-PF RenaissanceRe Holdings Ltd

-0.10 (-0.40%)

USD 7.82B
SPNT Siriuspoint Ltd

-0.07 (-0.49%)

USD 2.42B
HG Hamilton Insurance Group, Ltd.

+0.39 (+2.19%)

USD 1.98B
PRE-PJ PartnerRe Ltd.

-0.05 (-0.28%)

N/A
RNR-PG RenaissanceRe Holdings Ltd.

+0.05 (+0.27%)

N/A
SPNT-PB SiriusPoint Ltd.

-0.06 (-0.24%)

N/A
EG Everest Group Ltd

-1.89 (-0.49%)

N/A
RGA Reinsurance Group of America

-1.62 (-0.74%)

N/A
RNR Renaissancere Holdings Ltd

-2.42 (-0.91%)

N/A
BNRE-A Brookfield Reinsurance Ltd.

N/A

N/A

ETFs Containing BNRE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Reinsurance) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.10% 80% B- 86% B+
Dividend Return 0.54% 11% F 11% F
Total Return 22.64% 82% B 84% B
Trailing 12 Months  
Capital Gain 35.23% 89% A- 88% B+
Dividend Return 0.79% 29% F 9% A-
Total Return 36.02% 89% A- 86% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.96% 78% C+ 73% C
Dividend Return 12.20% 78% C+ 68% D+
Total Return 0.24% 14% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 15.95% 44% F 62% D
Risk Adjusted Return 76.51% 100% F 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.